SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke. Broome DT. J Clin Endocrinol Metab 2023;108:e1450-e1451.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Broome DT. SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke. J Clin Endocrinol Metab 2023;108:e1450-e1451.
PMID: 37061813